Association of Depression Risk with Patient Experience, Healthcare Expenditure, and Health Resource Utilization Among Adults with Atherosclerotic Cardiovascular Disease
Approximately 20% of patients with atherosclerotic cardiovascular disease (ASCVD) suffer from depression.
To compare healthcare expenditures and utilization, healthcare-related quality of life, and patient-centered outcomes among ASCVD patients, based on their risk for depression (among those without depression), and those with depression (vs. risk-stratified non-depressed).
Design and Setting
The 2004–2015 Medical Expenditure Panel Survey (MEPS) was used for this study.
Adults ≥ 18 years with a diagnosis of ASCVD, ascertained by ICD-9 codes and/or self-reported data. Individuals with a diagnosis of depression were identified by ICD-9 code 311. Participants were stratified by depression risk, based on the Patient Health Questionnaire-2.
A total of 19,840 participants were included, translating into 18.3 million US adults, of which 8.6% (≈ 1.3 million US adults) had a high risk for depression and 18% had a clinical diagnosis of depression. Among ASCVD patients without depression, those with a high risk (compared with low risk) had increased overall and out-of-pocket expenditures (marginal differences of $2880 and $287, respectively, both p < 0.001), higher odds for resource utilization, and worse patient experience and healthcare quality of life (HQoL). Furthermore, compared with individuals who had depression, participants at high risk also reported worse HQoL and had higher odds of poor perception of their health status (OR 1.83, 95% CI [1.50, 2.23]) and poor patient-provider communication (OR 1.29 [1.18, 1.42]).
The sample population includes self-reported diagnosis of ASCVD; therefore, the risk of underestimation of the cohort size cannot be ruled out.
Almost 1 in 10 individuals with ASCVD without diagnosis of depression is at high risk for it and has worse health outcomes compared with those who already have a diagnosis of depression. Early recognition and treatment of depression may increase healthcare efficiency, positive patient experience, and HQoL among this vulnerable population.
KEY WORDSatherosclerotic cardiovascular disease depression healthcare economics healthcare-related quality of life patient experience
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they do not have a conflict of interest.
- 1.Okunrintemi V, Spatz ES, Di Capua P, Salami JA, Valero-Elizondo J, Warraich H, Virani SS, Blaha MJ, Blankstein R, Borden WB, Dharmarajan K, Ting H, Krumholz HM, Nasir K. Patient-provider communication and health outcomes among individuals with atherosclerotic cardiovascular disease in the United States: Medical expenditure panel survey 2010 to 2013. Circ Cardiovasc Qual Outcomes. 2017, 10(4).Google Scholar
- 2.Khera R, Valero-Elizondo J, Okunrintemi V, Saxena A, Das SR, de Lemos JA, Khrumholz HM, Nasir K. Association of out-of-pocket annual health expenditures with financial hardship in low-income adults with atherosclerotic cardiovascular disease in the United States. JAMA Cardiol. 2018;3:729–738.CrossRefGoogle Scholar
- 7.Annapureddy A, Valero-Elizondo J, Khera R, Grandhi GR, Spatz ES, Dreyer RP, Desai NR, Krumholz HM, Nasir K. Association between financial burden, quality of life, and mental health among those with atherosclerotic cardiovascular disease in the United States. Circ Cardiovasc Qual Outcomes. 2018;11:e005180.Google Scholar
- 12.“Medical Expenditure Panel Survey.” Retrieved June 17th, 2019, from http://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp.
- 13.“IRB Exemption.” Retrieved June 17th, 2019, from http://www.hhs.gov/ohrp/regulations-and-policy/decision-trees/-c2.
- 15.Shao H, Mohammed MU, Thomas N, Babazadeh S, Yang S, Shi Q, Shi L. Evaluating excessive burden of depression on health status and health care utilization among patients with hypertension in a nationally representative sample from the Medial Expenditure Panel Survey (MEPS 2012). J Nerv Ment Dis. 2017;205:397–40.CrossRefGoogle Scholar
- 24.Hardin J, HIilbe J. Generalized linear models and extensions. College Station: StataCorp LP, Stata Press; 2012.Google Scholar
- 41.Coulter SA, Campos K. Identify and treat depression for reduced cardiac risk and improved outcomes. Tex Heart Inst J. 2012;39(2):231–4.Google Scholar
- 42.Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, Mark BM, Sheps DS, Taylor BC, Froelicher ES. AHA science advisory. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American heart association prevention committee to the council on cardiovascular nursing, council on clinical cardiology, council on epidemiology and prevention, and interdisciplinary council on quality of care outcomes research. Endorsed by the American psychiatric association. Prog Cardiovasc Nurs. 2009;24(1):19–26.CrossRefGoogle Scholar
- 44.Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O’Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation.. 2018;137:e67-e492.CrossRefGoogle Scholar